Survival of patients with de novo myelodysplastic syndromes (MDS) and del(5q)

被引：0
|
作者：
Gritsaev, S. [1 ]
Martinkevitch, I. [1 ]
Petrova, E. [1 ]
Kostroma, I. [1 ]
Ivanova, M. [1 ]
Sergeev, A. [1 ]
Tiranova, S. [1 ]
Potichonova, N. [1 ]
机构：
[1] Inst Hematol & Transfusiol, St Petersburg, Russia
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70192-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-144
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [41] MEGAKARYOCYTOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WITH AND WITHOUT DEL(5+)
    PODOLAKDAWIDZIAK, M
    GEDDES, D
    BOWEN, D
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 (02) : 115 - 116
  • [42] Myelodysplastic syndromes 5q deletion in childhood
    Iriani, A.
    LEUKEMIA RESEARCH, 2013, 37 : S93 - S93
  • [43] LENALIDOMIDE (LEN) IN MYELODYSPLASTIC (MDS) DEL(5Q) PATIENTS: A SINGLE INSTITUTION POPULATION-BASED EXPERIENCE
    Pelizzari, A.
    Cerqui, E.
    Schieppati, F.
    Borlenghi, E.
    Pagani, C.
    Bellotti, D.
    Rossi, G.
    HAEMATOLOGICA, 2013, 98 : 580 - 580
  • [44] Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring
    Jaedersten, Martin
    Karsan, Aly
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 177 - 180
  • [45] Prognostic value of low platelets in MDS patients with del(5q)
    Galili, N.
    Ahmed, A.
    Quddus, F.
    Jandani, S.
    Gul, Z.
    Siddiki, A.
    Mumtaz, M.
    Mehdi, M.
    Devuni, D.
    Raza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Cytopenias correlate with response to lenalidomide in del 5q MDS patients
    Sekeres, M. A.
    Maciejewski, J. P.
    Giagounidis, A.
    Wride, K.
    Knight, R.
    List, A.
    LEUKEMIA RESEARCH, 2007, 31 : S37 - S38
  • [47] Effect of Lenalidomide (LEN) Exposure on Response and Outcomes in Patients (Pts) with Lower-Risk Non-Del(5q) Myelodysplastic Syndromes (MDS)
    Garcia-Manero, Guillermo
    Santini, Valeria
    Almeida, Antonio
    Fenaux, Pierre
    Gatterman, Norbert
    Ozawa, Keiya
    Goldberg, Stuart L.
    Weaver, Jerry
    Sugrue, Mary M.
    BLOOD, 2016, 128 (22)
  • [48] Survival, prognostic factors, and leukemic transformation in a multicenter study of 241 patients with MDS and del(5q)
    Germing, U.
    Hildebrandt, B.
    Symeonidis, A.
    Cermak, J.
    Pfeilstoecker, M.
    Noesslinger, T.
    Sekkeres, M.
    Maciejewski, J.
    Haase, D.
    Schlenk, R.
    Schanz, J.
    Seymour, J.
    Kenealy, M.
    Koeppler, H.
    Luebbert, M.
    Platzbecker, U.
    Valent, P.
    Blum, S.
    Ottmann, O.
    Goetze, K.
    Stauder, R.
    Kreuzer, K. A.
    Aul, C.
    Kuendgen, A.
    Giagounidis, A.
    LEUKEMIA RESEARCH, 2009, 33 : S74 - S74
  • [49] SF3B1 Mutations and Not TP53 Are Associated with Poor Outcomes in Patients with Del(5q) Myelodysplastic Syndromes (MDS)
    Chan, Onyee
    Al Ali, Najla
    Sallman, David A.
    Padron, Eric
    Lancet, Jeffrey E.
    Komrokji, Rami
    BLOOD, 2020, 136
  • [50] CHARACTERIZATION OF THE TRANSCRIPTIONAL ALTERATIONS OF PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROME
    Berastegui Zufiaurre, N.
    Serrano, G.
    Diaz Mazkiaran, A.
    Huerga, S.
    Garcia-Olloqui, P.
    Ainciburu, M.
    Alfonso, A.
    Vilas-Zornoza, A.
    San Martin, P.
    Lamo De Espinosa, J. M.
    Acha, P.
    Jimenez Solas, T.
    Molero, A.
    Montoro, M. J.
    Campelo, M.
    Valcarcel, D.
    Sole, F.
    Ochoa, I.
    Hernaez, M.
    Ezponda, T.
    Prosper, F.
    LEUKEMIA RESEARCH, 2023, 128
12345